In today's ACT Brief, we examine building governance into every trial stage, how agentic AI is compressing RTSM startup ...

In today's ACT Brief, we examine how cross-asset site partnerships drive data sharing, standardized eCOA templates ...

In this video interview, Liz Beatty, co-founder and chief strategy officer at Inato, shares results from a Sanofi COPD study ...

In this video interview, Abraham Gutman, founder and CEO of AG Mednet, shares his key takeaways from SCOPE X, including a ...

In today's ACT Brief, we examine AI replacing unreliable feasibility estimates with precise patient matching, three tensions ...

These tensions are not transient. They are pushing organizations to rethink their planning practices, operating models, ...

In today's ACT Brief, we examine AI-enabled site performance in a Sanofi COPD study, why statisticians raising early phase ...

In a recent video interview with Applied Clinical Trials, Abraham Gutman, founder and CEO of AG Mednet, discussed the concept ...

In today's ACT Brief, we examine why process architecture matters more than autonomous agentic AI, shifting RWE from ...

In this video interview, Sam Hinsley, statistics manager at Phastar, explains why early phase decisions are the foundation of the entire development pathway and what is at stake statistically when ...

Across 42 coordinators (mean 6.2 years’ experience), only 45% of problems were identified on average, indicating substantial ...

Despite clear data quality and regulatory advantages, paper-based clinical outcome assessments persist due to cost asymmetry, ...